Simplex Casting Standalone December 2024 Net Sales at Rs 47.92 crore, up 62.54% Y-o-Y
Quarterly Net Profit at Rs. 6.29 crore in December 2024 up 1210.94% from Rs. 0.48 crore in December 2023. EBITDA stands at Rs ...
3dnatives.com15h
3D Printed Human Skin Equivalents Help Identify Potential HSV Treatments
Using 3D bioprinting, researchers have developed a more effective method for testing potential HSV treatments.
Housing lottery for $285,000 Uniondale home is now open. Here's how to apply.
Applicants must be first-time homebuyers, have a credit score of at least 580 and possess at least 3% of the purchase price, ...
Hosted on MSN4d
Simplex To Build US$13 Million CNC Machine Factory in KSA
Egypt-based computer numerical control (CNC) machine manufacturer Simplex has secured US$13 million in funding through a ...
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for bullous pemphigoid by June 20, 2025.
Pharmabiz19m
US FDA accepts for priority review Sanofi & Regeneron’s Dupixent sBLA for the targeted treatment of bullous pemphigoid
US FDA accepts for priority review Sanofi & Regeneron’s Dupixent sBLA for the targeted treatment of bullous pemphigoid: Paris Wednesday, February 19, 2025, 12:00 Hrs [IST] The U ...
mRNA research explores new frontiers in celiac disease treatment
Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...
How NASA's Lunar Trailblazer will make a looping voyage to the moon
Before arriving at the moon, the small satellite mission will use the gravity of the sun, Earth, and moon over several months ...
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...